Timeline At The Top: What Witty Did At GSK
This article was originally published in Scrip
Executive Summary
Sir Andrew Witty has announced his intention to retire as CEO of GlaxoSmithKline PLC in March 2017. Having joined as a graduate trainee in 1985, he became CEO in 2008. Eight years is a long time to head up a big pharma company, and while Sir Andrew's detractors might argue that he has failed to deliver shareholder value, none can argue that it has been for lack of action. Here is a timeline of major events at GSK since the start of his tenure at the top.